144
Views
0
CrossRef citations to date
0
Altmetric
Articles

Assessment of topical steroid phobia in dermatology patients, a cross-sectional study from an urban area of Pakistan

, , , &
Pages 2331-2334 | Received 27 Jun 2021, Accepted 19 Jul 2021, Published online: 01 Aug 2021

Reference

  • Kragballe K. Topical corticosteroids: mechanisms of action. Acta Derm Venereol Suppl (Stockh)). 1989;151:7.
  • Gupta LK, Martin AM, Agarwal N, et al. Guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis: An Indian perspective. Indian J Dermatol Venereol Leprol. 2016;82(6):603–625.
  • Coondoo A, Phiske M, Verma S, et al. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol Online J. 2014;5(4):416–425.
  • Hengge UR, Ruzicka T, Schwartz RA, et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1–15.
  • Raffin D, Giraudeau B, Samimi M, et al. Corticosteroid phobia among pharmacists regarding atopic dermatitis in children: a national French survey. Acta Derm Venereol. 2016;96(2):177–180.
  • Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30(1):29–35.
  • Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatol. 2017;153(10):1036–1042.
  • Fisher DA. Adverse effects of topical corticosteroid use. Western Journal of Medicine. 1995;162(2):123.
  • Moret L, Anthoine E, Aubert-Wastiaux H, et al. TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One. 2013;8(10):e76493.
  • Gonzales F, Ramdane N, Delebarre‐Sauvage C, et al. Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP® scale: prevalence, risk factors and the impact of therapeutic patient education. J Eur Acad Dermatol Venereol. 2017;31(3):e172–e174.
  • Song SY, Jung S-Y, Kim E. Steroid phobia among general users of topical steroids: a cross-sectional nationwide survey. J Dermatolog Treat. 2019;30(3):245–250.
  • Stalder JF, Aubert H, Anthoine E, et al. Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score. Allergy. 2017;72(11):1713–1719.
  • Charman C, Morris A, Williams H. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931–936.
  • Aubert‐Wastiaux H, Moret L, Le Rhun A, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165(4):808–814.
  • Fukaya M, Sato K, Sato M, et al. Topical steroid addiction in atopic dermatitis. Drug Healthc Patient Saf. 2014;6(131):131–138.
  • Hon KLE, Kam WYC, Leung TF, et al. Steroid fears in children with eczema. Acta Paediatr. 2006;95(11):1451–1455.
  • Fischer G. Compliance problems in paediatric atopic eczema. Australas J Dermatol. 1996;37 Suppl 1:S10–S13.
  • Müller SM, Tomaschett D, Euler S, et al. Topical corticosteroid concerns in dermatological outpatients: a cross-sectional and interventional study. Dermatology. 2016;232(4):444–452.
  • Choi E, Chandran NS, Tan C. Corticosteroid phobia: a questionnaire study using TOPICOP score. Singapore Med J. 2020;61(3):149–153.
  • Contento M, Cline A, Russo M. Steroid Phobia: A review of prevalence, risk factors, and interventions. Am J Clin Dermatol. 2021:1–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.